Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: GC Genome Corporation

Market Cap 115B 74.74M 65.31M 60.41M 56.38M 106M 7.06B 107M 718M 279M 3.47B 281M 275M 12.06B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 55.54M 36.12K 31.56K 29.19K 27.25K 51.15K 3.41M 51.52K 347K 135K 1.68M 136K 133K 5.83M EV / Sales 2026 *
1.42x
EV / Sales 2027 * 0.95x
Free-Float
49.59%
Yield 2026 *
-
Yield 2027 * -
1 day+0.21%
1 week-8.82%
Current month-19.27%
1 month-28.21%
3 months-38.48%
6 months-30.77%
Current year-28.74%
1 week 4,660
Extreme 4660
5,710
1 month 4,660
Extreme 4660
7,190
Current year 4,660
Extreme 4660
9,520
1 year 4,660
Extreme 4660
10,250
3 years 4,660
Extreme 4660
15,180
5 years 4,660
Extreme 4660
15,180
10 years 4,660
Extreme 4660
15,180
Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Director TitleAgeSince
Director/Board Member 57 30/03/2023
Date Insider Type Main position Quantity % Market Cap.
17/06/25Free

Chief Executive Officer

169,285 -
17/06/25Free 138,250 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.21%-8.82%-52.02% - 74.93M
-2.41%+4.13%+32.62%+326.06% 33.14B
-0.31%-3.63%-2.16%+8.73% 20.98B
-1.20%-1.93%-24.93%-44.26% 6.95B
+4.34%-1.60%+2.31%+71.37% 4.23B
+2.20%+4.39%+14.81%+49.81% 2.9B
-4.47%-7.58%-28.90%+830.54% 1.75B
+0.12%-2.61%-8.65%-66.59% 1.68B
+7.62%-0.81%+44.44%-24.96% 1.65B
-1.64%-0.13%+12.67%-4.84% 1.58B
Average +0.44%-1.25%-0.98%+127.32% 7.49B
Weighted average by Cap. -0.89%+1.00%+12.54%+165.96%

Financials

2026 *2027 *
Net sales 39B 25.36M 22.16M 20.5M 19.13M 35.91M 2.4B 36.18M 244M 94.77M 1.18B 95.21M 93.14M 4.09B 48.8B 31.73M 27.73M 25.65M 23.94M 44.94M 3B 45.27M 305M 119M 1.47B 119M 117M 5.12B
Net income - -
Net Debt -59.4B -38.62M -33.75M -31.22M -29.14M -54.7M -3.65B -55.1M -371M -144M -1.79B -145M -142M -6.23B -68.8B -44.74M -39.09M -36.16M -33.75M -63.36M -4.23B -63.82M -430M -167M -2.08B -168M -164M -7.22B
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
22/06/26 4,860.00 +0.21% 193,941
19/06/26 4,850.00 -6.91% 156,603
18/06/26 5,210.00 -4.05% 188,178
17/06/26 5,430.00 +4.22% 374,911
16/06/26 5,210.00 -2.07% 84,395

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!